Supportive Care News & Features
This study's information can inform policy issues, particularly the collection of patient-reported outcome data and its use in clinical practice.
Study authors suggest that oncologists and oncology providers can help design effective, personalized workplace accommodations for patients with cancer.
Patients who reported better clinician communication or an improved satisfaction with their treatment were more likely to be adherent.
Interprofessional practice provides benefits to patients, team members, and the health care system, by working collaboratively to support and assist each other.
According to the AACI, proposed budget cuts by the White House would likely mean a cut of close to $1 billion for the National Cancer Institute.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
Availability of important services and adequacy of care are among the factors explaining low numbers of patients with hematologic cancers being referred for hospice care.
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated.
Despite the availability of palliative and supportive care at major cancer centers, patients may encounter barriers to accessing these services.
The early integration of palliative care shortly after diagnosis of some incurable cancers improves both a patient's coping abilities and overall quality of life.
The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.
The modern opioid epidemic is forcing health care providers and government agencies to reevaluate pain management, but there is a lack of data regarding the risk of opioid-misuse among vulnerable populations.
Researchers analyzed the outcomes of 7060 patients with SCLC from the SEER database to determine the rates of new CEs among patients treated with chemotherapy plus RT or chemotherapy alone.
During the pre-chemotherapy period, which lasted a median 48 days from diagnosis, the average cost per payment was $16,208, 41% of which was due to inpatient care.
Pain management continues to be a challenge for patients with pancreatic cancer, though CPN may provide significant pain relief and an opportunity to reduce the amount of required narcotics.
Researchers evaluated data from 14,715 men with PCa from the Taiwan National Health Insurance Research Database, of whom 24.3% underwent bilateral orchiectomies and 75.7% received GnRHa therapy.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Long-term Survival From Ipilimumab/Nivolumab Combination in Metastatic Melanoma
- Ginkgo Biloba and Cancer
- Repeat T790M Testing Recommended for TKI-resistant Patients With NSCLC
- Nivolumab Plus Chemotherapy Improves Overall Survival and Response Rate in NSCLC
- Pembrolizumab Plus Pemetrexed, Carboplatin Prolongs Survival in NSCLC
- Curative-intent Surgery for Cancer Increases Risk of New Persistent Opioid-use
- HIV-associated Head and Neck Cancers Have Unique Molecular Characteristics
- Pembrolizumab Significantly Prolongs OS Compared With Chemotherapy in NSCLC
- Cost, Insurance Status May Affect Patient Adherence to TKI Therapy for CML
- Affordable Care Act Linked to Lower Rates of Cancer Diagnosis Among Uninsured